Business Medical Devices Orthopaedics Technology

Global Size and Growth of Spine Surgery Market Segments

Last updated: July 7, 2011 7:56 am

PatrickDriscoll

2 Min Read

The worldwide market for technologies and products in spine surgery is over $12 billion annually. The market is diverse in its technologies and its geographic distribution. It remains staunchly one of the most resilient medical device markets in the face of pressures in healthcare for cost reduction. With this economic foundation, it has supported a steady stream of innovation that is projected to continue for the next ten years.

The worldwide market for technologies and products in spine surgery is over $12 billion annually. The market is diverse in its technologies and its geographic distribution. It remains staunchly one of the most resilient medical device markets in the face of pressures in healthcare for cost reduction. With this economic foundation, it has supported a steady stream of innovation that is projected to continue for the next ten years.

Below illustrates graphically the segments in the spine surgery market by displaying each segment by sales volume (size and position along horizontal axis) and compound annual growth rate through 2020 (position on vertical axis). This exhibit is not intended to be confusing, but it does illustrate that there are numerous market segments that are close in size and growth rate, and only a couple that stand out in either case, notably the high growth and low current size of axial lumbar interbody fusion and the high size and lower growth of posterior pedicle screw fusion systems.

Source: MedMarket Diligence, LLC; Report #M520 (publication pending).

TAGGED:medical devices medical technology orthopaedics spinal surgery

Share This Article

By PatrickDriscoll

Follow:

I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses.Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.